Skip to Content

Sponsors

No results

Keywords

No results

Types

No results

Search Results

Events

No results
Search events using: keywords, sponsors, locations or event type
When / Where
All occurrences of this event have passed.
This listing is displayed for historical purposes.

Presented By: Biomedical Engineering

Biomedical Engineering Seminar Series

"Revolutionizing Immunotherapy: Bioengineered Immune Organs and Nanoscale Technologies," with Ankur Singh, Ph.D.

A speaker talking to a group of students in a classroom. A speaker talking to a group of students in a classroom.
A speaker talking to a group of students in a classroom.
Revolutionizing Immunotherapy: Bioengineered Immune Organs and Nanoscale Technologies
Abstract:
The human immune system is a marvel of biological complexity, yet its dysfunction underlies numerous diseases. Designing vaccines, immunomodulatory drugs, and cell therapies against infections, cancer, inflammatory conditions, and age-related disorders requires a detailed understanding of how immune cells form and activate in primary, secondary, and ectopic tertiary immune organs. Traditionally, research on the immune system has been restricted to in vivo approaches, which do not allow for the detailed control of intracellular and extracellular processes, and to 2D in vitro models, which lack physiological relevance. These models are being investigated to understand immune function and dysfunction at the cellular, tissue, and organ levels. In this talk, I will discuss my laboratory’s effort in developing synthetic, human ex vivo immune organoids to replicate the structure and function of immune tissues. I will discuss strategies to combine engineered materials and immune cells from individuals to generate antibody-secreting cells in a dish or as organ-on-chip against viral and bacterial infections and describe immunogenicity testing efforts. I will further describe the use of human immune organoids in oncology and drug development space, and subsequently describe the integration of immune organoids with complex mucosal organ-on-chip technologies, with applications in inflammation, infection, and oncology. Complementing this, I will introduce nanoengineered wires functionalized with cationic polymers to program naive T cells without pre-activation, a critical advancement for adoptive T-cell therapies. By delivering single or multiple microRNAs, I will describe how nanowires modulate T-cell fitness, influencing proliferation, phenotypic differentiation, and effector molecule secretion. These programmed T cells exhibit enhanced in vivo protection against intracellular pathogens, with tailored differentiation into T cell subtypes.
A speaker talking to a group of students in a classroom. A speaker talking to a group of students in a classroom.
A speaker talking to a group of students in a classroom.

Back to Main Content